FDA Approves Expanded Use of Adacel (Tdap) Vaccine for Repeat Vaccination

BRIDGEWATER, N.J., Jan. 14, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved the expanded use of Adacel® (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine Adsorbed) to include repeat...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news